Betaseron Pertains To Hepatic Toxicity. Berlex, Inc. reminded healthcare professionals of the prescribing information for ‘Betaseron’ (interferon beta-1b) as it pertains to hepatic toxicity. ‘Betaseron’ is approved for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations.
Post-Marketing Safety Surveillance
There have been reports during post-marketing safety surveillance of serious hepatic injury including autoimmune hepatitis and severe liver damage leading to hepatic failure and transplant.
absence of clinical symptoms
Liver function testing is recommended at regular intervals (one, three, and six months) following introduction to ‘Betaseron’ therapy, and then periodically thereafter in the absence of clinical symptoms.
Need Legal Help Regarding Betaseron?
Our attorneys for Betaseron side effects are here to help you when you need it the most.